Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
Salles, Gilles, Prof, Seymour, John Francis, Prof, Offner, Fritz, Prof, López-Guillermo, Armando, MD, Belada, David, MD, Xerri, Luc, Prof, Feugier, Pierre, Prof, Bouabdallah, Réda, MD, Catalano, John Vincent, FRACP, Brice, Pauline, MD, Caballero, Dolores, MD, Haioun, Corinne, Prof, Pedersen, Lars Moller, MD, Delmer, Alain, Prof, Simpson, David, FRACP, Leppa, Sirpa, MD, Soubeyran, Pierre, Prof, Hagenbeek, Anton, Prof, Casasnovas, Olivier, MD, Intragumtornchai, Tanin, Prof, Fermé, Christophe, MD, da Silva, Maria Gomes, MD, Sebban, Catherine, MD, Lister, Andrew, Prof, Estell, Jane A, FRACP, Milone, Gustavo, MD, Sonet, Anne, MD, Mendila, Myriam, MD, Coiffier, Bertrand, Prof, Tilly, Hervé, Prof
Published in The Lancet (British edition) (2011)
Published in The Lancet (British edition) (2011)
Get full text
Journal Article